Human Metabolome Technologies, Inc. (6090)

Market cap
¥3.7B
P/E ratio
17.3x
Provides high-sensitivity analysis of metabolic compounds to pharmaceutical companies, research institutions, and manufacturers to support drug development and product testing.
Period EndRevenue (Million JPY)YoY (%)
Jun 30, 20251,455+8.12%
Jun 30, 20241,346+3.57%
Jun 30, 20231,299+6.21%
Jun 30, 20221,223+8.83%
Jun 30, 20211,124+0.50%
Jun 30, 20201,118+13.05%
Jun 30, 2019989+18.61%
Mar 31, 2019834-11.09%
Mar 31, 2018938+2.63%
Mar 31, 2017914+17.15%
Mar 31, 2016780+13.66%
Mar 31, 2015687+12.49%
Mar 31, 2014610+22.98%
Mar 31, 2013496-4.92%
Mar 31, 2012522
AI Chat